Sarcoma
¶ 1 Leave a comment on paragraph 1 0 [et_pb_section admin_label=”Seksjon” fullwidth=”on” specialty=”off”][et_pb_fullwidth_post_title admin_label=”Fullbreddes innleggstittel” title=”on” meta=”off” author=”on” date=”on” categories=”on” comments=”on” featured_image=”on” featured_placement=”background” parallax_effect=”off” parallax_method=”on” text_orientation=”right” text_color=”light” text_background=”on” text_bg_color=”rgba(21,150,137,0.9)” module_bg_color=”rgba(255,255,255,0)” title_font=”|on|||” title_font_size=”35px” title_all_caps=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid” module_id=”header-image-and-text”]
¶ 2 Leave a comment on paragraph 2 0
¶ 3 Leave a comment on paragraph 3 0 [/et_pb_fullwidth_post_title][/et_pb_section][et_pb_section admin_label=”Seksjon” fullwidth=”off” specialty=”off”][et_pb_row admin_label=”Rad”][et_pb_column type=”2_3″][et_pb_text admin_label=”Tekst” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
Sarcomas are an uncommon type of cancer, but it is quite frequent in young patients. The Sarcoma project is prospective in that we will systematically collect samples and analyze mutations in patients recruited from around the country. It is crucial that we are working closely with sarcoma teams in all health regions.
¶ 5 Leave a comment on paragraph 5 0
NoSarC – Norwegian Sarcoma Consortium
Personalized treatment for orphan cancer
¶ 6 Leave a comment on paragraph 6 0 As a part of our national effort to evaluate and develop strategies for personalized cancer therapy, we are initiating a population-based investigation of tumor mutations in Norwegian patients with high-grade sarcoma. This is a collaboration with the clinical sarcoma groups in all Norwegian health regions, and the intention is to collect all available biopsies from these tumors over 2-3 years.
¶ 7 Leave a comment on paragraph 7 0 The tumor sequencing effort is supported by the Norwegian Cancer Genomics Consortium, funded by the Norwegian Research Council, and we also have support from the Regional Health Authorities in South-east Norway and the Cancer Society.
¶ 8 Leave a comment on paragraph 8 0 The poster presentation of the project at the Connective Tissue Oncology Society’s meeting in 2016 can be read here.
¶ 9 Leave a comment on paragraph 9 0
¶ 10 Leave a comment on paragraph 10 0 June 14: NoSarC receives one of 4 grants of 7 MNOK from the Cancer Society’s “Krafttak mot kreft” charity.
¶ 11 Leave a comment on paragraph 11 0 Lilly og Karl Larssons Foundation generously supports a research nurse position.The interdisciplinary Sarcoma Group at OUS – Radiumhospitalet: from left Ola Myklebost (Mesenchymal cancer biology), Bodil Bjerkehagen (Pathologi), Leonardo A Meza-Zepeda (Translational Genomics), Kjetil Boye (Clinical sarcoma Research), Kirsten Sundby-Hall (Head sarcoma Program) and Olga Zaikova (National Competence Service for Sarcoma)Current consortium members:
¶ 12 Leave a comment on paragraph 12 0 Haukeland Sarcoma Centre (Nina Jebsen)
¶ 13 Leave a comment on paragraph 13 0 Haukeland Centre for hereditary cancer (Hildegunn Vetti)
¶ 14 Leave a comment on paragraph 14 0 UNN University Hospital of Northern Norway (Eivind Smeland)
¶ 15 Leave a comment on paragraph 15 0 OUS- Radiumhospitalet Sarcoma group (Kirsten Sundby-Hall, Kjetil Boye, Bodil Bjerkehagen, Leonardo Meza-Zepeda, Ola Myklebost)
¶ 16 Leave a comment on paragraph 16 0 OUS – Rikshospitalet Pediatric Oncology (Heidi Glosli)
¶ 17 Leave a comment on paragraph 17 0 St Olavs University Hospital Sarcoma Group (Heidi Knobel)
¶ 18 Leave a comment on paragraph 18 0 National Competence Centre for Sarcomas (Olga Zaikova)
¶ 19 Leave a comment on paragraph 19 0 [/et_pb_text][/et_pb_column][et_pb_column type=”1_3″][et_pb_sidebar admin_label=”Nyhetsarkiv og konferanser” orientation=”left” area=”primary” background_layout=”light” remove_border=”off”]
¶ 20 Leave a comment on paragraph 20 0
¶ 21 Leave a comment on paragraph 21 0 [/et_pb_sidebar][/et_pb_column][/et_pb_row][/et_pb_section]